South Indian Bank. Institutional Equities. 1QFY19 Result Update. Performance Troughs, Pessimism Peaks BUY. 23 July 2018

Similar documents
South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

Punjab National Bank

Punjab National Bank

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

9,500 7,914 8, NIM

Institutional Equities

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

2,09,057 1,85,859 2,17, (4.1) NIM

Gillette India. Institutional Equities. 1QFY18 Result Update

Jamna Auto Industries

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

Indian Oil Corporation

Colgate-Palmolive (India)

Muthoot Finance. Institutional Equities. 3QFY18 Result Update. Funding Cost Decline Combines With Operating Leverage BUY.

18,948 15,784 18, NIM

Operating expenses tracked lower than core total income growth as ABL displayed continued

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018

Dalmia Bharat Enterprises

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

93,707 77,814 90, NIM

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

Punjab National Bank

State Bank of India. Institutional Equities. 3QFY19 Result Update BUY

EBITDA 5,076 3, , EBITDA

Bharat Financial Inclusion

3,746 2,551 3, NIM

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY

Federal Bank. Institutional Equities. Management Meet Update

PNB Housing Finance. Institutional Equities. 2QFY19 Result Update BUY. Relatively Soft Quarter Not Structural In Nature.

Punjab National Bank

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017

Punjab National Bank

Muthoot Finance. Institutional Equities. 2QFY19 Result Update. Weak quarter not structural in any way BUY. 10 December 2018

Bata India. Institutional Equities. 1QFY19 Result Update BUY

9,251 7,812 8, NIM

Muthoot Finance. Institutional Equities. 1QFY19 Result Update

Indian Oil Corporation

9,807 8,007 9, NIM

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY

Institutional Equities

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

Manappuram Finance. Institutional Equities. 2QFY19 Result Update BUY

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

Institutional Equities

State Bank of India. Institutional Equities. 1QFY18 Result Update

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

DCB Bank. Institutional Equities. 3QFY19 Result Update. Decisive Move Into Higher RoE Trajectory BUY. 17 January 2019

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN

Institutional Equities

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

Institutional Equities

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE

Bank of Baroda. Institutional Equities. 4QFY18 Result Update BUY

Institutional Equities

Axis Bank. Institutional Equities. 3QFY19 Result Update BUY. Management Says 18% RoE In The Realm Of Possibility. 30 January 2019

EBITDA 6,223 6,511 (4.4) 5, EBITDA

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN

Institutional Equities

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Institutional Equities

Institutional Equities

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA

Dalmia Bharat Enterprises

Dabur India. Institutional Equities. 1QFY19 Result Update

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport

Valuation and Outlook. Growth (%) PAT (Rs cr)

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE

Institutional Equities

The Ramco Cements. Institutional Equities. Event Update BUY

EBITDA 1,585 1,917 (17.3) 1,673 (5.2) EBITDA

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY.

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely

Institutional Equities

Initiating Coverage. Uflex Ltd.

Dalmia Bharat Enterprises

Financial summary. Year

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update

Institutional Equities

Institutional Equities

E&P To Stay Strong; Consumer Segment To Revive

Institutional Equities

EBITDA 5,019 4,211 5, EBITDA

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1%

La Opala RG. Institutional Equities. 1QFY18 Result Update

Transcription:

1QFY19 Result Update Institutional Equities South Indian Bank 23 July 2018 Reuters: SIBK.BO; Bloomberg: SIB IN Performance Troughs, Pessimism Peaks South Indian Bank (SBL) reported 1QFY19 results with the key strategic takeaways being: (1) SBL applied the concept of inherent weakness conservatively leading to total slippages of Rs 6.06bn but management has guided for Rs 6-7bn slippages over the remainder of FY19 (2) Core fee income growth was tepid due to the absence of PSLC income (~Rs 200mn in 1QFY18) (3) Hit from (a) gratuity revision (Rs 204.5mn) and (b) MTM loss (Rs 343mn) that remained unamortized as of 4QFY18 were, conservatively, fully absorbed (4) NIM contracted ~10 bps QoQ and ~20 bps YoY to 2.6% but management guided for NIM reversion to 2.8% in ~6 months on the back of MCLR resets. (See comprehensive conference call takeaways on page 2; see initiating coverage report here). Per se, on the results front, SIBL posted NII growth of 7.3% YoY at Rs4,943mn, PPOP decline of 28.9% YoY at Rs2,696mn and PAT decline of 77.3% YoY at Rs230mn. We have revised our estimates for FY19/FY20 and have retained Buy rating on SBL, revising our target price to Rs26 (from Rs30 earlier) and valuing the stock at 0.75x FY20E P/BV. SBL applied the concept of inherent weakness conservatively leading to total slippages of Rs 6.06bn: One social infra account (Rs 1.05bn), two cashew sector accounts (Rs 1.17bn) and an EPC account (Rs 0.22bn) slipped upon conservative application of the concept of inherent weakness. As things stand, there is no account standard at SBL that is NPA at another bank. There were no slippages from large syndicated / consortium corporate accounts. However, total corporate slippages were Rs 3.08bn mainly from smaller non-consortium accounts. Slippages from SME segment spiked to Rs 2.26bn and were the primary negative surprise. Of these, ~Rs 1bn were from accounts that had previously been accorded RBI 180-day dispensation for MSMEs. None of the sub-investment grade corporate accounts (18.3% of corporate book on internal rating) are in default. Management guided for total slippages of Rs 6-7bn over the remainder of FY19 and credit costs of ~100 bps for the full year FY19. Core fee income growth was tepid due to the absence of PSLC income: Core fee income grew 8.3% YoY to Rs 910mn. Last year, about Rs 800bn of PSLC fee income was garnered, of which about a fourth was booked in 1QFY18. This was absent in 1QFY19. Business development officers have now been deployed effectively at branches and will start to perform with some lag on the liabilities and cross-sell front. Some incipient signs of improved performance is visible with SA growth of ~6% QoQ. Accelerated amortization of gratuity and MTM hit further compressed bottomline, NIM compression is transient: While SBL had availed respective RBI dispensations for spreading gratuity revision and MTM hits in 4QFY18, they, conservatively, chose to fully absorb the unamortized quantums of Rs 204.5mn and Rs 343 mn during the quarter. MCLR resets over the next ~6 months will aid NIM reversion to ~2.8%. Majority of loans are on 1-year MCLR and recent MCLR hike amounts to 25 bps. NIM compression on account of interest reversals was 9 bps. Valuation and outlook: We have revised our NII estimates by -3.2%/-1.1%, PPOP estimates by -6.4%/- 4.9% and PAT estimates by -15.4%/-8.3% for FY19/FY20, respectively. We have retained Buy rating on SBL, revising our target price on it to Rs26 (from Rs30 earlier) and valuing the stock at 0.75x FY20E P/BV. NBIE Values your patronage- Vote for The Team in the Asia Money poll 2018. Click Here BUY Sector: Banking CMP: Rs18 Target Price: Rs26 Upside: 41% Shivaji Thapliyal Research Analyst shivaji.thapliyal@nirmalbang.com +91-22-6273 8068 Key Data Current Shares O/S (mn) 1,809.5 Mkt Cap (Rsbn/US$mn) 33.3/483.7 52 Wk H / L (Rs) 35/18 Daily Vol. (3M NSE Avg.) 11,030,740 Price Performance (%) 1 M 6 M 1 Yr South Indian Bank (21.5) (43.0) (35.9) Nifty Index 2.4 0.0 11.8 Source: Bloomberg Y/E March (Rsmn) 1QFY19 1QFY18 4QFY18 YoY (%) QoQ (%) Interest income 16,539 14,907 15,890 11.0 4.1 Interest expenses 11,597 10,300 10,968 12.6 5.7 Net interest income 4,943 4,607 4,922 7.3 0.4 NIM (%) 2.6 2.8 2.7 (20bps) (13 bps) Non-interest income 1,459 2,193 1,787 (33.5) (18.3) Operating income 6,402 6,800 6,709 (5.9) (4.6) Staff costs 2,111 1,670 1,933 26.4 9.2 Other operating expenses 1,594 1,336 1,667 19.4 (4.3) Total operating expenses 3,705 3,005 3,600 23.3 2.9 Cost-to-income (%) 57.9 44.2 53.7 1,369bps 422bps Pre-provision profit 2,696 3,795 3,109 (28.9) (13.3) Provisions 2,315 2,243 1,486 3.2 55.8 PBT 381 1,552 1,623 (75.4) (76.5) Tax 151 537 482 (71.9) (68.7) -Effective tax rate 39.5 34.6 29.7 493bps 987bps PAT 230 1,015 1,141 (77.3) (79.8) EPS (Rs) 0.1 0.6 0.6 (77.4) (79.8) BV (Rs) 29.1 27.7 29.0 4.9 0.4 Deposits 7,24,880 6,57,910 7,20,296 10.2 0.6 Advances 5,54,440 4,64,980 5,45,629 19.2 1.6

Comprehensive Conference Call Takeaways Growth drivers in the advances portfolio were mortgages- 66%, MSME- 21%, agri- 14.2% and auto loans- 31% on a YoY basis. NIM compressed this quarter on account of increased deposit rates and interest reversals contributed 9 bps to NIM compression. The management recently hiked MCLR rates by 25 bps this quarter. Resets will take place over 6 months. The management has guided for NIM to improve to ~2.8% in about 6 months. Management has guided for 1% credit cost for the full year. Slippages in this quarter mainly comprised of Rs.3080mn from corporate segment, Rs.2260mn from MSME, retail & others contributed Rs.610mn and agri Rs.110mn. Corporate slippage comprised of one large account of Rs.1050mn, two cashew accounts worth Rs.1170mn and one EPC account of Rs.220mn. The management stated that they applied the principle of inherent weakness of the fundamentals of the business rather than recovery history in order to evaluate accounts for stress recognition. The management stated that the large corporate book has stabilised as such. There were no corporate slippages from large syndicated/ consortium accounts which were a cause of worry in the past due to lower recovery rates. Break-up of slippages from MSME segment was as follows: Rs590mn trading firms, Rs380mn textile, Rs.360mn food processing, Rs.180mn professional services, Rs.170mn engineering, Rs.150mn metal products, Rs.110mn leather products, Rs.100mn contractors and Rs.130mn from other manufacturing industries. The management has now revised its guidance for slippages for the pending 3 quarters cumulatively to Rs.6000-7000mn. The management is expecting recovery to be not less than Rs. 5000mn in FY19 on account of strong recovery initiatives and platform in place. ~Rs.1000mn worth of MSME slippages which took advantage of RBI dispensation in the previous quarter were classified as NPAs this quarter. The outstanding MSME loans still availing such dispensation is ~Rs.500mn. SIB does not maintain a watchlist on MSME loans. The management stated that the credit appraisal mechanism has been centralized in all segments except for gold loans. SIB has created a centralized credit committee based sanctioning system whereas this was earlier under the control of individual regional heads. The management stated that there s no widespread slippage pressure on the MSME segment as such. There has been some GST transitioning pressure on MSMEs. Within Kerala, there have been issues in the cashew and marine segments. The management stated that there has been very selective sanction with respect to Kerala cashew exposure in the last 3 years. SIB is ensuring reasonable prospective stability with the SME segment through credit underwriting, processing and monitoring. The management is confident of stably growing ~20% YoY in this segment. As per SIB s internal rating of corporate borrower profile, ~18% of the total corporate loan book is below BBB grade vis-a-vis ~9% as per external rating. The management stated none of the below BBB accounts are part of outstanding NPAs. The management also stated that none of these sub-investment accounts are in default. Gross SR book stood at Rs.13110mn with an accumulated provision of Rs.2650mn. SIB provided Rs.40mn in this quarter on SR book. Some of these accounts were RBI indentified NCLT accounts. As resolution occurs, more comfort will come on this front. 2 South Indian Bank

SIB has classified all accounts associated with DCCO issues as NPAs. The bank experienced reasonable traction on SA front with a QoQ growth of ~6%. The deployment of business development officers is relatively recent and the full impact of the same will be felt with a lag. The bank s loan book exposure to NCLT Lists 1 and 2 are to 2 accounts worth Rs.3360mn. Provisions on this exposure is ~50%. The management stated that the share of NPAs in MSME is broadly in line with geographical branch distribution. About 45% of the total MSME slippages were from Kerala in this quarter. SIB s focus on adequate security aims to have collateral comprising of immovable assets such as land, building etc beyond primary security such as receivables etc. The management stated that the board has not arrived at a decision on the capital raising front. They also stated that they still have some room to raise Tier 2 capital. The management stated that the LGD on slipped assets will not be high, particularly for MSME business, given that SIB has minimal unsecured business and strong collateral. The management stated that there is no account which is classified as NPA in other banks, is performing with SIB. SIB checks CRILC data to know if accounts are stressed at other banks. GNPA reductions comprised Rs.130mn of cash recoveries and Rs.240mn of upgrades. There were no write-offs during the quarter. Exhibit 1: Financial summary Y/E March (Rsmn) FY16 FY17 FY18 FY19E FY20E Net interest income 15,097 16,754 19,655 24,673 31,985 Pre-provision profit 8,794 12,146 14,808 16,113 21,192 PAT 3,333 3,925 3,349 4,714 7,611 EPS (Rs) 2.5 2.2 1.9 2.5 4.0 ABV (Rs) 28.5 26.9 29.0 31.1 34.6 P/E (x) 7.5 8.5 9.9 7.4 4.6 P/ABV (x) 0.6 0.7 0.6 0.6 0.5 GNPAs (%) 3.8 2.5 3.6 4.0 3.5 NNPAs (%) 2.9 1.5 2.6 2.7 2.4 RoA (%) 0.5 0.6 0.4 0.5 0.7 RoE (%) 9.0 9.0 6.6 8.5 12.2 Exhibit 2: Actual performance versus our estimates (Rsmn) 1QFY19 1QFY18 4QFY18 YoY (%) QoQ (%) 1QFY19E Devi. (%) Net interest income 4,943 4,607 4,922 7 0.42 5,796 (15) Pre-provision profit 2,696 3,795 3,109 (29) (13) 3,917 (31) PAT 230 1,015 1,141 (77) (80) 267 (14) Exhibit 3: Change in our estimates Revised estimate Earlier estimate % Revision FY19E FY20E FY19E FY20E FY19E FY20E Net interest income (Rsmn) 24,673 31,985 25,479 32,332 (3.2) (1.1) NIM (%) 3.0 3.2 3.1 3.2 (6bps) 5bps Operating profit (Rsmn) 16,113 21,192 17,220 22,290 (6.4) (4.9) Profit after tax (Rsmn) 4,714 7,611 5,570 8,302 (15.4) (8.3) 3 South Indian Bank

Jul-13 Dec-13 May-14 Oct-14 Mar-15 Aug-15 Jan-16 Institutional Equities Jun-16 Nov-16 Apr-17 Sep-17 Feb-18 Jul-18 Exhibit 4: One-year forward P/BV (x) 1.20 1.10 1.00 0.90 0.80 0.70 0.60 0.50 P/BVPS Mean +1 SD -1 SD +2 SD -2 SD 4 South Indian Bank

Financials Exhibit 5: Income statement Y/E March (Rsmn) FY16 FY17 FY18 FY19E FY20E Interest income 55,572 58,471 61,928 74,972 92,369 Interest expenses 40,475 41,716 42,273 50,300 60,383 Net interest income 15,097 16,754 19,655 24,673 31,985 Fee income 519 550 557 720 945 Other Income 4,656 6,606 7,816 6,107 7,345 Net revenues 20,272 23,910 28,028 31,500 40,276 Operating expenses 11,478 11,764 13,220 15,387 19,083 -Employee expenses 6,923 6,765 7,132 8,185 9,635 -Other expenses 4,556 4,999 6,088 7,202 9,448 Pre-provision profit 8,794 12,146 14,808 16,113 21,192 Provisions 3,696 6,144 9,809 8,970 9,661 -Loan loss provision 3,911 6,201 7,008 7,836 8,643 -Provision for investment 432 422 3,090 1,134 1,018 -Other provisions -647-478 -289 0 0 PBT 5,097 6,002 4,999 7,143 11,532 Tax 1,764 2,077 1,650 2,429 3,921 PAT 3,333 3,925 3,349 4,714 7,611 Exhibit 7: Balance sheet Y/E March (Rsmn) FY16 FY17 FY18 FY19E FY20E Equity Capital 1,350 1,803 1,809 1,899 1,899 Reserves & Surplus 37,106 46,682 50,623 57,141 63,843 Shareholder's Funds 38,456 48,485 52,432 59,040 65,742 Deposits 5,57,207 6,61,175 7,20,296 8,51,247 10,24,102 -Current deposits 19,831 27,526 30,576 37,455 49,157 -Saving deposits 1,04,758 1,29,938 1,40,841 1,74,506 2,30,423 -Term deposit 4,32,618 5,03,712 5,48,879 6,39,286 7,44,522 Borrowings 26,150 19,578 40,434 58,567 71,042 Other liabilities 12,936 13,884 13,697 30,875 50,167 Total liabilities 6,34,749 7,43,122 8,26,859 9,99,729 12,11,053 Cash/Equivalent 32,745 38,877 42,210 55,654 67,898 Advances 4,10,857 4,63,895 5,45,629 6,54,755 7,98,801 Investments 1,47,439 1,94,297 1,83,631 2,23,535 2,66,160 Fixed Assets 4,870 6,561 6,808 7,489 8,237 Other assets 38,837 39,492 48,581 58,297 69,956 Total assets 6,34,749 7,43,122 8,26,859 9,99,729 12,11,053 Exhibit 6: Key ratios Y/E March FY16 FY17 FY18 FY19E FY20E Growth (%) NII growth 10.5 11.0 17.3 25.5 29.6 Pre-provision profit growth (0.4) 38.1 21.9 8.8 31.5 PAT growth 8.2 17.7 (14.7) 40.8 61.4 Business (%) Deposit growth 7.3 18.7 8.9 18.2 20.3 Advance growth 9.9 12.9 17.6 20.0 22.0 Business growth 8.4 16.2 12.5 19.0 21.0 CD 73.7 70.2 75.8 76.9 78.0 CASA 22.4 23.8 23.8 24.9 27.3 Operating efficiency (%) Cost-to-income 56.6 49.2 47.2 48.8 47.4 Cost-to-assets 1.9 1.7 1.7 1.7 1.7 Productivity (Rsmn) Business per branch 1,160.7 1,323.6 1,482.3 1,703.6 1,994.4 Business per employee 138.2 161.3 173.7 198.1 224.1 Profit per branch 4.0 4.6 3.9 5.3 8.3 Profit per employee 0.5 0.6 0.5 0.6 0.9 Spreads (%) Yield on advances 11.1 10.2 9.4 9.8 10.0 Yield on investments 6.4 7.2 6.7 7.3 7.3 Cost of deposits 7.1 6.5 5.8 6.1 6.1 Yield on assets 9.9 9.5 8.8 9.2 9.3 Cost of funds 7.2 6.6 5.9 6.0 6.0 NIMs 2.7 2.7 2.8 3.0 3.2 Capital adequacy (%) Tier I 9.8 10.9 10.4 10.1 9.4 Tier II 2.0 1.5 2.3 2.0 1.9 Total CAR 11.8 12.4 12.7 12.1 11.3 Asset quality (%) Gross NPAs 3.8 2.5 3.6 4.0 3.5 Net NPAs 2.9 1.5 2.6 2.7 2.4 Specific provision coverage 22.7 39.3 27.3 32.1 33.4 Slippage 4.1 3.9 3.6 2.4 2.1 Credit cost 1.0 1.4 1.4 1.2 1.1 Return (%) RoE 9.0 9.0 6.6 8.5 12.2 RoA 0.5 0.6 0.4 0.5 0.7 RoRWA 1.0 1.0 0.7 0.9 1.2 Per share EPS 2.5 2.2 1.9 2.5 4.0 BV 28.5 26.9 29.0 31.1 34.6 ABV 19.5 23.0 21.0 21.7 24.6 Valuation (x) P/E 7.5 8.5 9.9 7.4 4.6 P/BV 0.6 0.7 0.6 0.6 0.5 P/ABV 0.9 0.8 0.9 0.8 0.7 5 South Indian Bank

Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Institutional Equities Rating track Date Rating Market price (Rs) Target price (Rs) 26 March 2018 Buy 23 28 15 May 2018 Buy 26 30 23 July 2018 Buy 18 26 Rating track graph 40 35 30 25 20 15 Not Covered Covered 6 South Indian Bank

DISCLOSURES This Report is published by Nirmal Bang Equities Private Limited (hereinafter referred to as NBEPL ) for private circulation. NBEPL is a registered Research Analyst under SEBI (Research Analyst) Regulations, 2014 having Registration no. INH000001436. NBEPL is also a registered Stock Broker with National Stock Exchange of India Limited and BSE Limited in cash and derivatives segments. NBEPL has other business divisions with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. NBEPL or its associates have not been debarred / suspended by SEBI or any other regulatory authority for accessing / dealing in securities Market. NBEPL, its associates or analyst or his relatives do not hold any financial interest in the subject company. NBEPL or its associates or Analyst do not have any conflict or material conflict of interest at the time of publication of the research report with the subject company. NBEPL or its associates or Analyst or his relatives do not hold beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of this research report. NBEPL or its associates / analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. NBEPL or its associates have not received any compensation or other benefits from the company covered by Analyst or third party in connection with the research report. Analyst has not served as an officer, director or employee of Subject Company and NBEPL / analyst has not been engaged in market making activity of the subject company. Analyst Certification: I, Shivaji Thapliyal, the research analyst is the author of this report, hereby certifies that the views expressed in this research report accurately reflects my personal views about the subject securities, issuers, products, sectors or industries. It is also certified that no part of the compensation of the analyst was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst principally responsible for the preparation of this research report and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. 7 South Indian Bank

Disclaimer Stock Ratings Absolute Returns BUY > 15% ACCUMULATE -5% to15% SELL < -5% This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. NBEPL is not soliciting any action based upon it. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any such transaction. In preparing this research, we did not take into account the investment objectives, financial situation and particular needs of the reader. This research has been prepared for the general use of the clients of NBEPL and must not be copied, either in whole or in part, or distributed or redistributed to any other person in any form. If you are not the intended recipient you must not use or disclose the information in this research in any way. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. NBEPL will not treat recipients as customers by virtue of their receiving this report. This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject NBEPL & its group companies to registration or licensing requirements within such jurisdictions. The report is based on the information obtained from sources believed to be reliable, but we do not make any representation or warranty that it is accurate, complete or up-to-date and it should not be relied upon as such. We accept no obligation to correct or update the information or opinions in it. NBEPL or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. NBEPL or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This information is subject to change without any prior notice. NBEPL reserves its absolute discretion and right to make or refrain from making modifications and alterations to this statement from time to time. Nevertheless, NBEPL is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries. Before making an investment decision on the basis of this research, the reader needs to consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular investment needs, objectives and financial circumstances. There are risks involved in securities trading. The price of securities can and does fluctuate, and an individual security may even become valueless. International investors are reminded of the additional risks inherent in international investments, such as currency fluctuations and international stock market or economic conditions, which may adversely affect the value of the investment. Opinions expressed are subject to change without any notice. Neither the company nor the director or the employees of NBEPL accept any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. Here it may be noted that neither NBEPL, nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profit that may arise from or in connection with the use of the information contained in this report. Copyright of this document vests exclusively with NBEPL. Our reports are also available on our website www.nirmalbang.com Access all our reports on Bloomberg, Thomson Reuters and Factset. Team Details: Name Email Id Direct Line Rahul Arora CEO rahul.arora@nirmalbang.com - Girish Pai Head of Research girish.pai@nirmalbang.com +91 22 6273 8017 / 18 Dealing Ravi Jagtiani Dealing Desk ravi.jagtiani@nirmalbang.com +91 22 6273 8230, +91 22 6636 8833 Pradeep Kasat Dealing Desk pradeep.kasat@nirmalbang.com +91 22 6273 8100/8101, +91 22 6636 8831 Michael Pillai Dealing Desk michael.pillai@nirmalbang.com +91 22 6273 8102/8103, +91 22 6636 8830 Nirmal Bang Equities Pvt. Ltd. Correspondence Address B-2, 301/302, Marathon Innova, Nr. Peninsula Corporate Park, Lower Parel (W), Mumbai-400013. Board No. : 91 22 6273 8000/1; Fax. : 022 6273 8010 8 South Indian Bank